For this diabetes-themed issue of The Endocrinologist, I wanted to highlight the great work being published in Endocrinology, Diabetes & Metabolism Case Reports on the subject of diabetic ketoacidosis (DKA).

While DKA is typically associated with new-onset type 1 diabetes, insulin withdrawal and acute illness, there is increasing evidence that patients with type 2 diabetes are also vulnerable to DKA. Five of the ten most-read cases in Endocrinology, Diabetes & Metabolism Case Reports in 2017 were on the subject of DKA. The most-read was ‘Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma’ by Prashanth Rawla and colleagues. The report discusses two interesting cases that demonstrate the rare situation in which DKA presents with normal blood glucose levels.

These and other cases can all be found on the website. They involve DKA and complications or related diseases (Hamman’s syndrome, Cushing’s syndrome, pregnancy, hypocapnic seizure), as well as populations not typically associated with DKA (cases of type 2 diabetes), and DKA resulting from or being affected by medication (e.g. resperidone, nivolumab and canagliflozin). Endocrinology, Diabetes & Metabolism Case Reports has become a home for cases reporting on the complications of DKA.

Maralyn Druce, Co-Editor-in-Chief, Endocrinology, Diabetes & Metabolism Case Reports

The Society for Endocrinology endorses Endocrinology, Diabetes & Metabolism Case Reports, along with eleven other learned societies. Browse the case reports at www.edmcasereports.com.